Results
Demographic characteristics, left atrial size, and ejection fraction
displayed no statistically significant differences between the groups.
Follow-up duration was comparable, with 29.1 ± 15 months for the ECVS
group and 31.9±20 months for the NoECVS group (p=0.24). Notably, syncope
recurrence was significantly lower in the ECVS group (2 cases vs. 4
cases, Log Rank p=0.04). Moreover, the Hazard ratio revealed a five-fold
higher risk of syncope recurrence in the NoECVS group.